CTN: Northern New England Node
CTN:新英格兰北部节点
基本信息
- 批准号:7498062
- 负责人:
- 金额:$ 40万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-30 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS clinical trial groupAIDS preventionAIDS/HIV problemAbstinenceAbuse ReportingAcademic Medical CentersAcademic TrainingAcademyAccountingAccreditationAcquired Immunodeficiency SyndromeAcuteAddressAdherenceAdministratorAdmission activityAdolescenceAdolescentAdolescent DevelopmentAdolescent PsychiatryAdoptedAdoptionAdultAdverse effectsAdverse eventAdvisory CommitteesAdvocateAffectAfrican AmericanAgeAgreementAlaska NativeAlcohol consumptionAlcohol dependenceAlcohol or Other Drugs useAlcoholismAlcoholsAll SitesAmbulatory Care FacilitiesAmericanAmerican IndiansAmerican Psychological AssociationAnti-Retroviral AgentsAnxiety DisordersAppendixApplications GrantsApplied ResearchAppointmentArchivesAreaArizonaArmeniaArtsAsiansAttentionAttention deficit hyperactivity disorderAuthorshipAwardAwarenessBackBaseline SurveysBedsBehaviorBehavior TherapyBehavioralBehavioral MedicineBehavioral SciencesBeliefBenefits and RisksBenzodiazepinesBinding SitesBiologicalBiological AssayBiometryBipolar DisorderBloodBook ChaptersBooksBostonBrain imagingBudgetsBuprenorphineBusinessesCAB protocolCD4 Lymphocyte CountCalibrationCaliforniaCardiovascular systemCaringCase ManagementCase ManagerCase MixesCase Report FormCategoriesCaucasiansCaucasoid RaceCensusesCenters for Disease Control and Prevention (U.S.)Certificate of ConfidentialityCertificationCervicalChairpersonCharacteristicsChargeChildChild AbuseChild PsychiatryChildhoodChinaChronic DiseaseChronologyCigaretteCigarette SmokerCitiesClassificationClientClient satisfactionClinicClinic VisitsClinicalClinical Practice GuidelineClinical PsychologyClinical ResearchClinical ServicesClinical TreatmentClinical TrialsClinical Trials Data Monitoring CommitteesClinical Trials DesignClinical Trials NetworkClinical effectivenessCocaineCodeCognitiveCognitive TherapyCollaborationsCollectionColorCombination Drug TherapyCommittee MembersCommunicationCommunication ResearchCommunitiesCommunity Health CentersCommunity HealthcareCommunity SurveysComorbidityCompetenceComplementComplexComputer softwareConditionConduct Clinical TrialsConfidentialityConflict (Psychology)ConfusionConsensusConsentConsent FormsConsultConsultationsContinuing EducationContinuity of Patient CareContractsControl GroupsCounselingCountryCouples TherapyCriminal JusticeCuesDSM-IVDaceDailyDataData AggregationData AnalysesData CollectionData QualityData ReportingDatabasesDay CareDecision MakingDelawareDependenceDepressed moodDetectionDeveloped CountriesDeveloping CountriesDevelopmentDiabetes MellitusDiagnosisDiagnosticDiffusionDiffusion of InnovationDirect CostsDisciplineDiseaseDistance EducationDoctor of MedicineDoctor of PhilosophyDocumentationDomestic ViolenceDoseDropoutDropsDrug AddictionDrug Administration RoutesDrug CourtsDrug EvaluationDrug Metabolic DetoxicationDrug abuseDrug resistanceDrug usageDrug userEarly identificationEating DisordersEconomic ConditionsEconomicsEducationEducational ActivitiesEducational AssessmentEducational CurriculumEducational InterventionEducational process of instructingEducational workshopEffectivenessEffectiveness of InterventionsElectronic MailElectronicsElementsEligibility DeterminationEmployeeEmployee StrikesEnd PointEnrollmentEnsureEnvironmentEquationEquilibriumEquipmentEthicsEthnic OriginEvaluationEventEvidence based practiceEvidence based treatmentExclusion CriteriaExerciseExpenditureFaceFamilyFamily PhysiciansFamily psychotherapyFatigueFeasibility StudiesFeedbackFeelingFeesFellowshipFemaleFeverFollow-Up StudiesFosteringFoundationsFrustrationFundingFunding AgencyFutureGenderGender IssuesGeneral HospitalsGeneral PopulationGenieGeographyGiftsGoalsGovernment AgenciesGrantGraphGroup TherapyGuided imageryGuidelinesHIVHIV InfectionsHIV SeropositivityHIV prevention trials networkHalfway HousesHandHappinessHeadacheHealthHealth AllianceHealth Insurance Portability and Accountability ActHealth PersonnelHealth ProfessionalHealth ServicesHealth Services AccessibilityHealth Services ResearchHealth StatusHealth behavior changeHealthcareHealthcare SystemsHepatitis CHepatitis C virusHigh Risk WomanHighly Active Antiretroviral TherapyHispanicsHome environmentHome visitationHomelessnessHospitalsHourHouse CallHuman ResourcesHuman immunodeficiency virus testHybridsIllicit DrugsImpairmentIncentivesIndependent Scientist AwardIndiaIndividualIndustryInfantInfectionInformation SystemsInformed ConsentInjecting drug userInjection of therapeutic agentInpatientsInstitute of Medicine (U.S.)InstitutesInstitutionInstructionInsuranceIntakeIntentionInterest GroupInternationalInternational Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)InterventionIntervention StudiesInterviewInvestigationJournalsKenyaKnowledgeLaboratoriesLatinaLatinoLawsLeadLeadershipLearningLebanonLeftLegalLengthLength of StayLettersLicensingLifeLightLinguisticsLinkLiteratureLiving WillsLocationLogistic RegressionsLongevityMailsMaineMaintenanceManaged CareManicManualsManuscriptsMarijuanaMassachusettsMaster of Public HealthMeasurementMeasuresMediatingMediator of activation proteinMedicalMedical centerMedicareMedicare/MedicaidMedicineMental DepressionMental HealthMental Health ServicesMental disordersMentorsMeta-AnalysisMethadoneMethodologyMethodsMethylphenidateMicroprocessorMid-Career Clinical Scientist Award (K24)MindMinorityMinority GroupsMissionModalityModelingModificationMonitorMood DisordersMoraleMothersMulti-Institutional Clinical TrialMutationMyanmarNaloxoneNamesNational Institute of Drug AbuseNational Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Research Service AwardsNatureNauseaNeedlesNeurologyNew EnglandNew HampshireNewsletterNewspapersNicotine DependenceNone or Not ApplicableNumbersNursesNursing HomesOccupationsOffice of Administrative ManagementOnline SystemsOperative Surgical ProceduresOpiate AddictionOpioidOpioid AnalgesicsOrganizational ChangeOrganizational ModelsOther ResourcesOutcomeOutcome AssessmentOutcome MeasureOutcome StudyOutpatientsPacific Island AmericansPainPain managementPaperParticipantPatient EducationPatient MonitoringPatient Self-ReportPatient currently pregnantPatientsPatternPediatric HospitalsPeer ReviewPerformancePersonal SatisfactionPersonsPharmaceutical PreparationsPharmacotherapyPhasePhase III Clinical TrialsPhase TransitionPhysician ExecutivesPhysiciansPilot ProjectsPlacebosPlasmaPlayPliabilityPoliciesPopulationPopulation ProgramsPositioning AttributePost-Traumatic Stress DisordersPostdoctoral FellowPostpartum WomenPractice GuidelinesPregnant WomenPreparationPrevalencePreventionPrevention educationPrevention programPrincipal InvestigatorPrivacyProblem SolvingProceduresProcessProductivityProfessional counselorProgram DescriptionProgress ReportsProtocols documentationProviderPsyche structurePsychiatristPsychiatryPsychologistPsychologyPsychopharmacologyPsychostimulant dependencePsychotherapyPsychotic DisordersPublic HealthPublic PolicyPublicationsPublishingPurposeQualifyingQuality ControlQuality of CareQuality of lifeQuestionnairesRNARaceRandomizedRandomized Controlled Clinical TrialsRandomized Controlled TrialsRangeRateReadinessReadingRecommendationRecording of previous eventsRecordsRecoveryRecruitment ActivityRed CrossRegistered nurseRegulationRegulatory AffairsRehabilitation therapyRelapseRelative (related person)Report (document)ReportingResearchResearch ActivityResearch DesignResearch EthicsResearch Ethics CommitteesResearch InfrastructureResearch InstituteResearch MethodologyResearch PersonnelResearch Project GrantsResearch TrainingResidenciesResidential TreatmentResistanceResolutionResourcesRestReview CommitteeReview LiteratureRhode IslandRiskRisk BehaviorsRisk ReductionRiversRoleRole playing therapyRouteRunningRuralRussiaSafe SexSafetySample SizeSamplingScheduleSchizophreniaScienceScoreScreening procedureSecureSelf EfficacySelf MedicationSeminal fluidSeriesSerious Adverse EventServicesSeveritiesSex BehaviorSex CharacteristicsSexually Transmitted DiseasesShapesShippingShipsSideSiteSleep disturbancesSmokeSmokerSmokingSocial FunctioningSocial WorkSocial WorkersSocietiesSolidSolutionsSourceSpecific qualifier valueStaff DevelopmentStagingStandards of Weights and MeasuresStatistical Data InterpretationStratificationStressStructureSubgroupSubstance Abuse, OtherSubstance AddictionSubstance Use DisorderSubstance abuse problemSumSummary ReportsSupervisionSupport GroupsSupport of ResearchSurveysSurvivorsSymptomsSystemTarget PopulationsTechniquesTechnology TransferTelephoneTestingTextbooksTherapeuticTherapeutic community techniqueThinkingTimeTimeLineTobaccoToxicologyTrainingTraining ActivityTraining ProgramsTraining and EducationTranslatingTransportationTraumaTravelTreatment EffectivenessTreatment EfficacyTreatment ProtocolsTreatment StepTreatment outcomeTriageTubeUSA GeorgiaUnderrepresented MinorityUnited NationsUnited States National Institutes of HealthUnited States Substance Abuse and Mental Health Services AdministrationUniversitiesUpdateUpper armUrineValidationVermontVideotapeViralViral Load resultViral load measurementVirusVirus DiseasesVisionVisitVisual Analogue Pain ScaleVulnerable PopulationsWeekWestern Asia GeorgiaWithdrawalWomanWood materialWorkWorkplaceWorld Health OrganizationWritingYouthacamprosateaddictionadolescent smokingaminoglutethimide/danazol/hydrocortisone/tamoxifenantiretroviral therapyauthoritybasebehavioral healthcareerchronic paincigarette smokingclinical research siteclinically relevantcollegecomparison groupcomputerized data processingconceptcontingency managementcopingcostcost effectivecost effectivenesscytarabine/daunorubicin/thioguaninedata integritydata managementdaydemographicsdepressive symptomsdesigndesiredisorder later incidence preventiondissemination researchdocument outlinesdual diagnosisearly /brief intervention /therapyeditorialeffectiveness clinical trialeffectiveness researchethnic minority populationexpectationexperiencefallsfollow-upgroup counselinghealth care service utilizationhealth related quality of lifehospital bedhuman subjectimplementation researchimplementation trialimprovedinclusion criteriaindexinginnovationinstrumentinterestintervention programjuvenile delinquentlecturesmalemedical schoolsmedical specialtiesmedication compliancemembermenmotivational enhancement therapymultidisciplinarynamed groupneglectneuropsychologicalnewsnicotine abusenicotine patchnovel strategiesoffenderorganizational structureoutreachparitypatient oriented researchpediatricianpeerperformance sitepillpreferenceprescription documentprescription procedurepreventprobationproblem solving therapyprofessorprogramsprospectiveprotocol developmentpsychoeducationpsychologicpsychological distresspsychopharmacologicpsychosocialpublic policy on tobaccoquality assuranceracial and ethnicracial differencerehearsalresearch and developmentresearch studyresearch to practiceresilienceresponseretinal rodssatisfactionself helpservice utilizationsevere mental illnesssexskillssmoking cessationsocialspecial interest groupstatisticsstudy characteristicssubstance abusersuccesssymposiumtherapy adherencetherapy designtherapy developmenttooltopiramatetraining projecttransitional housingtransmission processtreatment centertreatment durationtreatment effecttreatment programtreatment sitetreatment trialtrial comparingvolunteerwillingnessyoung adult
项目摘要
This is a proposal for renewal of "Clinical Trials Network (CTN): Harvard University Northern New
England Node," submitted in response to RFA-DA-07-001 "Announcement of a Limited Competition of the
National Drug Abuse Treatment Clinical Trials Network (U10)." The Northern New England Node (NNEN)
brings together research expertise, sophisticated community treatment programs (CTPs), and a wide variety
of patients being treated in diverse settings and multiple levels of care. The Node is characterized by a
partnership between academic researchers and community-based treatment providers throughout 5 New
England states to design and implement addiction treatment studies in community-based treatment
programs.
The NNEN has demonstrated outstanding progress since entering the CTN in 2002, with a combination of
scientific and administrative leadership and excellent trial performance. The NNEN is the Lead Node on a
multi-site study of prescription opioid analgesic dependence treatment, and has played a major scientific
leadership role in the development and implementation of two CTN studies of patients with substance use
disorder and attention deficit hyperactivity disorder. Administrative leadership is exemplified by participation
by NNEN members on the 4 key CTN national committees; the NNEN is the only Node to be represented on
all of these committees. NNEN members have also been elected to chair several national committees and
work groups, demonstrating their excellent reputation among their CTN colleagues. Trial performance has
been exemplary: the NNEN has participated in more trials and randomized more participants than any other
Node entering in 2002; and has randomized more than twice as many participants in the 2005-2006 Node
Trial Performance Report than the average for a CTN Node. Moreover, according to the most recent NIDA
Trial Progress Report, the NNEN is the only Node (other than the 2 new Nodes entering the CTN in 2005) to
meet or exceed expectations on every performance indicator of every trial the Node has entered. NNEN
CTPs have adopted a number of new evidence-based practices, and have themselves disseminated
information about these practices regionally, nationally, and internationally.
This proposal highlights the accomplishments of the Northern New England Node in the funding period
since September 2002. While the Node has made outstanding progress, the proposal also details a number
of enhancements to strengthen the NNEN during the renewal period. During the next three years, the NNEN
plans to continue to advance the mission of the CTN by implementing and testing state-of-the-art drug abuse
treatment interventions, so that clinical programs will use the best treatments available and patients will
receive the full benefit of the evolving science of addiction treatment.
这是一份更新“临床试验网络(CTN):哈佛大学北方新
英格兰节点,”提交以回应RFA-DA-07-001“有限竞争的公告,
国家药物滥用治疗临床试验网络(U10)。“北方新英格兰节点(NNEN)
汇集了研究专业知识,复杂的社区治疗计划(CTP),以及各种各样的
患者在不同的环境和多层次的护理中接受治疗。节点的特征在于
学术研究人员和社区治疗提供者之间的合作伙伴关系贯穿5个新
英格兰各州将在社区治疗中设计和实施成瘾治疗研究
程序.
自2002年加入CTN以来,NNEN取得了显著进展,
科学的行政领导能力和出色的审判业绩。NNEN是一个
多地点研究阿片类药物依赖的处方镇痛治疗,并发挥了重大的科学
在药物使用患者的两项CTN研究的开发和实施中发挥领导作用
注意缺陷多动障碍和注意缺陷多动障碍。行政领导体现在参与
由NNEN成员在4个关键的CTN国家委员会; NNEN是唯一的节点,
所有这些委员会。NNEN成员还当选为几个国家委员会的主席,
工作组,展示了他们在CTN同事中的良好声誉。试验性能具有
作为典范:NNEN参与了更多的试验,随机分配了更多的参与者,比其他任何组织都多。
Node于2002年进入;并在2005-2006年Node中随机分配了两倍多的参与者
试验性能报告高于CTN节点的平均值。此外,根据最新的NIDA
试验进度报告,NNEN是唯一的节点(除了2005年进入CTN的2个新节点),
达到或超过节点已进入的每个试验的每个性能指标的预期。NNEN
现金转拨方案采用了一些新的循证做法,并自行传播
在区域、国家和国际上提供有关这些做法的信息。
本建议书强调了北方新英格兰节点在资助期内取得的成就
自2002年9月以来。虽然节点已经取得了突出的进展,但该提案还详细说明了一些
在续期期间,我们会加强该网络的功能。在接下来的三年里,
计划通过实施和测试最先进的药物滥用,继续推进CTN的使命
治疗干预,使临床项目将使用最好的治疗方法,患者将
接受不断发展的成瘾治疗科学的全部好处。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger D. Weiss其他文献
Associations between Childhood Abuse and Chronic Pain in Adults with Substance Use Disorders
儿童期虐待与患有药物滥用障碍的成人慢性疼痛之间的关联
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:2
- 作者:
Nadine R. Taghian;R. K. McHugh;M. Griffin;Alexandra R. Chase;Shelly F. Greenfield;Roger D. Weiss - 通讯作者:
Roger D. Weiss
A comparison of alcoholic and nonalcoholic drug abusers.
酒精和非酒精药物滥用者的比较。
- DOI:
10.15288/jsa.1988.49.510 - 发表时间:
1988 - 期刊:
- 影响因子:0
- 作者:
Roger D. Weiss;S. Mirin;M. Griffin;J. Michael - 通讯作者:
J. Michael
Pilot testing a novel remotely delivered intensive outpatient program for hospitalized patients with opioid use disorder
- DOI:
10.1186/s13722-025-00589-4 - 发表时间:
2025-08-01 - 期刊:
- 影响因子:3.200
- 作者:
Veronica Szpak;Andrea Velez Carc;Sara Prostko;Naomi Rosenblum;Rie Maurer;Lyndon J. Aguiar;Roger D. Weiss;Joji Suzuki - 通讯作者:
Joji Suzuki
Developing a remotely delivered intensive outpatient program adapted for hospitalized patients with opioid use disorder: A qualitative study
开发适合阿片类药物使用障碍住院患者的远程密集门诊项目:一项定性研究
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Veronica Szpak;Sara Prostko;Roger D. Weiss;Joji Suzuki - 通讯作者:
Joji Suzuki
Psychopathology in substance abusers: diagnosis and treatment.
药物滥用者的精神病理学:诊断和治疗。
- DOI:
- 发表时间:
1988 - 期刊:
- 影响因子:0
- 作者:
S. Mirin;Roger D. Weiss;J. Michael;M. Griffin - 通讯作者:
M. Griffin
Roger D. Weiss的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger D. Weiss', 18)}}的其他基金
Mentoring in Drug Abuse and Dual Diagnosis Research
药物滥用和双重诊断研究的指导
- 批准号:
7495195 - 财政年份:2007
- 资助金额:
$ 40万 - 项目类别:
Mentoring in drug abuse and dual diagnosis research
药物滥用和双重诊断研究的指导
- 批准号:
8382799 - 财政年份:2007
- 资助金额:
$ 40万 - 项目类别:
Mentoring in drug abuse and dual diagnosis research
药物滥用和双重诊断研究的指导
- 批准号:
8490326 - 财政年份:2007
- 资助金额:
$ 40万 - 项目类别:
Mentoring in drug abuse and dual diagnosis research
药物滥用和双重诊断研究的指导
- 批准号:
8897314 - 财政年份:2007
- 资助金额:
$ 40万 - 项目类别:
Mentoring in Drug Abuse and Dual Diagnosis Research
药物滥用和双重诊断研究的指导
- 批准号:
8101916 - 财政年份:2007
- 资助金额:
$ 40万 - 项目类别:
Mentoring in Drug Abuse and Dual Diagnosis Research
药物滥用和双重诊断研究的指导
- 批准号:
7322290 - 财政年份:2007
- 资助金额:
$ 40万 - 项目类别:
Mentoring in Drug Abuse and Dual Diagnosis Research
药物滥用和双重诊断研究的指导
- 批准号:
7675469 - 财政年份:2007
- 资助金额:
$ 40万 - 项目类别:
CTN: Harvard University Northern New England Node
CTN:哈佛大学新英格兰北部节点
- 批准号:
6570902 - 财政年份:2002
- 资助金额:
$ 40万 - 项目类别:
CTN: Harvard University Northern New England Node
CTN:哈佛大学北新英格兰节点
- 批准号:
7118296 - 财政年份:2002
- 资助金额:
$ 40万 - 项目类别:
相似海外基金
HIV/AIDS prevention and intervention: HIV surveillance methods, Per-exposure prophylaxis eligibility and HIV/STI testing behaviours among a cohort of people living with HIV.
HIV/艾滋病预防和干预:HIV 感染者群体中的 HIV 监测方法、每次暴露预防资格和 HIV/STI 检测行为。
- 批准号:
495195 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10013921 - 财政年份:2020
- 资助金额:
$ 40万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10181081 - 财政年份:2020
- 资助金额:
$ 40万 - 项目类别:
UCLA AIDS Prevention and Treatment Clinical Trials Unit
加州大学洛杉矶分校艾滋病预防和治疗临床试验单位
- 批准号:
10166309 - 财政年份:2020
- 资助金额:
$ 40万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10597008 - 财政年份:2020
- 资助金额:
$ 40万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10386931 - 财政年份:2020
- 资助金额:
$ 40万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
9921510 - 财政年份:2019
- 资助金额:
$ 40万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
9753631 - 财政年份:2019
- 资助金额:
$ 40万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
10265667 - 财政年份:2019
- 资助金额:
$ 40万 - 项目类别:
Closing the Gap: Involving Indigenous Elders and youth in HIV/AIDS prevention using participatory filmmaking
缩小差距:利用参与式电影制作让土著老年人和青年参与艾滋病毒/艾滋病预防工作
- 批准号:
364681 - 财政年份:2017
- 资助金额:
$ 40万 - 项目类别: